Mar 6, 2024
|
12:15 |
Prof. Dr. Pablo Sinues, University Children's Hospital Basel, University of Basel, Basel
|
Pharmacometabolomics guided by breath analysis |
V. van der Velpen |
Nov 15, 2023
|
12:15 |
Prof. Dr. med. Dagmar Meyer zu Heringdorf, Pharmazentrum Frankfurt, Frankfurt am Main |
News in cellular Ca2+ signalling by sphingosine 1-phosphate |
A. Huwiler
|
Nov 1, 2023
|
12:15 |
PD Dr. med. Tatiana Bremova-Ertl, Universitätsklinik für Neurologie, Inselspital, Bern |
N-Acetyl-L-Leucine: A symptomatic drug with neuroprotective potential? |
A. Huwiler
|
Oct 25, 2023
|
12:15 |
Prof. Dr. Özlem Tastan Bishop, Research Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, Rhodes University, Grahamstown/Makhanda, 6139, South Africa |
Proteins and missense mutations in health and disease |
C. Largiadèr
|
Oct 18, 2023
|
12:15 |
Prof. Dr. med. Pier Paolo Scaglioni, Division of Hematology Oncology, University of Cincinnati, USA |
Lipid metabolism regulates ferroptosis in lung cancer
|
G. Konstantinidou
|
Oct 11, 2023
|
12:15 |
PD Dr. med. Tatiana Bremova-Ertl, Universitätsklinik für Neurologie, Inselspital, Bern |
N-Acetyl-L-Leucine: A symptomatic drug with neuroprotective potential?
|
A. Huwiler
|
Sept 14, 2023
|
13:30 |
Prof. Matej Orešič, Örebro University, Sweden |
Metabolome and exposome in metabolic dysfunction associated steatotic liver disease. Place: Microscopy- lecture hall, Pathology |
M. Masoodi
|
June 22, 2023
|
12:15 |
Dr. Gergely Gyimesi, Department of Biomedical Research/Nephrology, University of Bern |
SLC Atlas: towards a unified view
|
A. Huwiler
|
Mar 15, 2023
|
12:15 |
Prof. Dr. Manuele Rebsamen, Department of Immunobiology, University of Lausanne |
Solute carriers in metabolism and (auto)immunity: molecular mechanisms and therapeutic potential |
G. Konstantinidou |
Mar 14, 2023
|
12:15 |
Prof. Dr. Andreas Strasser, The Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Australia |
How does the tumour suppressor p53 prevent the development of cancer? |
T. Kaufmann
|
Feb 28, 2023
|
14:00 |
Prof. Rami Aqeilan, Lautenberg Center for Immunology and Cancer Research, Hebrew University – Hadassah Medical School, Jerusalem, Israel |
Non-canonical roles for long and fragile genes in cancer and neuropathologies |
H-U Simon
|
Feb 1, 2023
|
12:15 |
PD Dr. Stephan Kellenberger, Department of Biomedical Sciences, University of Lausanne |
Cellular roles and molecular mechanisms of acid-sensing ion channels |
A. Huwiler
|
| Jan 18, 2023 |
12:15 |
Prof. Dr. Patrycja Nowak-Sliwinska, Institute of Pharmaceutical Sciences, University of Geneva |
Why one drug is not enough? |
G. Konstantinidou |
| Dec 19, 2022 |
12:15 |
Dr. Anna Brichkina, Center for Tumor Biology and Immunology , Philipps University of Marburg, Germany |
Targeting the tumor stroma: new concepts and potential approaches |
H-U. Simon |
Oct 12, 2022
|
12:15 |
Prof. Dr. Wolfgang Eberhardt, Pharmazentrum Frankfurt/ZAFES, Gothe University Frankfurt am Main |
Multifaceted roles of the E3 Ligase TRIM25 in colorectal cancer
|
A. Huwiler
|
Sept 21, 2022
|
12:15 |
Prof. Dr. med. Britta Maurer, Universitätsklinik für Rheumatologie und Immunologie, Inselspital, Bern |
Predictive potential of the integration of multi-source molecular data and imaging-based radiomic data in (experimental) fibrosing ILD
|
S. von Gunten
|
July 6, 2022
|
12:15 |
Priv. Doz. Dr. Gabriele Weitz-Schmidt, AlloCyte Pharmaceuticals AG, Basel |
Integrin targeting pharmacology - The mechanism of action matter |
A. Huwiler
|
| April 13, 2022 |
12:15 |
Dr. Michaela Medova, Department for BioMedical Research, University of Bern |
METworks - at the interface between radioresistance and behavior
|
G. Konstantinidou |
| Jan 19, 2022 |
12:15 |
Prof. Dr. Sebastian Leidel, Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern |
RNA modifications and disease: Cause or cure? |
A. Huwiler
|
